Invention Grant
- Patent Title: Targeting fibroblast invasion for pulmonary fibrosis
-
Application No.: US15761404Application Date: 2016-09-26
-
Publication No.: US10705074B2Publication Date: 2020-07-07
- Inventor: Paul W. Noble , Dianhua Jiang , Carol Jiurong Liang
- Applicant: CEDARS-SINAI MEDICAL CENTER
- Applicant Address: US CA Los Angeles
- Assignee: CEDARS-SINAI MEDICAL CENTER
- Current Assignee: CEDARS-SINAI MEDICAL CENTER
- Current Assignee Address: US CA Los Angeles
- Agency: McCarter & English, LLP
- Agent Beverly W. Lubit
- International Application: PCT/US2016/053743 WO 20160926
- International Announcement: WO2017/053952 WO 20170330
- Main IPC: C12N15/11
- IPC: C12N15/11 ; G01N33/50
Abstract:
The described invention provides a method for identifying a therapeutic compound effective to reduce invasiveness of fibroblasts characterized by a highly invasive phenotype obtained from a subject with idiopathic pulmonary fibrosis.
Public/Granted literature
- US20190170732A1 TARGETING FIBROBLAST INVASION FOR PULMONARY FIBROSIS Public/Granted day:2019-06-06
Information query
IPC分类:
